arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

INVO Fertility, Inc.

IVF
$2.03 ▼ -0.02 (-0.98%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
16 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
26
Health
Poor
Moderately Bearish
auto_awesome

Analytical Summary

INVO Fertility, Inc. faces fundamental challenges with weakness in Operating Margin (%). Investors should exercise caution and monitor for improvement in key metrics.

Market Cap —
Dividend Yield —
Revenue Growth 4.3% ↘
Op. Margin -105.8% ↗
ROIC -104.9% ↘
FCF / Share $-60.28 ↘
Trailing P/E —
Price / Book 0.2x
FCF Yield —
Debt / Equity 0.15
info Valuation on last close. End-of-day price, Nov 5, 2026.

16-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$6.84M
↑ +4.3% —
Net Income Profit after all expenses
$-23.32M
↓ -156.4% —
Operating Margin Operating profit as % of sales
-105.8%
↑ +14.6% 2th
FCF / Share Free cash flow per share
$-60.28
↓ -490.8% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
2
Financial Health ↓
53
Cash Quality ↓
33

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 16 years · 57 quarters